Insights

BSKB’s intellectual property attorneys write articles on important and timely topics in intellectual property law across a variety of industries. You’ll find the latest articles and industry insights here.

  • July 1, 2022

    "Pharma Patents Under Fire From Federal Circuit, Petitions Say"

    by Samantha Handler | Bloomberg Law

    BSKB's Hailey R. Bureau, Ph.D., was quoted in an article for Bloomberg Law regarding recent rulings by the US Court of Appeals for the Federal Circuit regarding strict enforcement of certain Patent Act provisions. These rulings regarding Section 112(a), a written description requirement and an enablement standard, have created a high burden for Applicants in the life science industry to overcome.

  • June 21, 2022

    Who Owns ‘Skin’? Kardashian’s ‘SKKN’ Facing Trademark Ambiguity

    by Kelcee Griffis | Bloomberg Law

    BSKB Partner Michael T. Smith was quoted recently in an article regarding Kim Kardashian's new skin care line, "SKKN by Kim".

  • May 20, 2022

    Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields

    by Hailey R. Bureau, T. Dwight McGee, Stephen Quirk, Rigoberto Hernandez, & Caley Allen | Chemistry Europe: European Chemical Societies Publishing

    BSKB’s Hailey Bureau, Ph.D., co-authored a research article entitled “Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields”. Although prepared during her time in graduate school, the paper has now been published on May 20, 2022 in ChemPhysChem.

  • April 29, 2022

    Responding to Examiner Rejections in Chem/Pharma/Bio Applications

    by Chad M. Rink and Briana Barron | Patent Law Institute

    BSKB’s Chad Rink recently co-lectured with Briana Barron during the 2022 Patent Law Institute (PLI) virtual meeting. Their topic was “Responding to Examiner Rejections in Chem/Pharma/Bio Applications.” Chad and Briana discussed recent court decisions covering written description, obviousness, and inequitable conduct.

  • April 26, 2022

    Label Ruling Upends Generic Medicine Makers

    by MaryAnne Armstrong | WIPR

    The effects of the ‘skinny label’ decision are being felt across pharma. MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch revisits GSK v Teva.

  • April 13, 2022

    Podcast: Leonard Svensson (BSKB) remarks on Impossible Food’s recent legal issues

    by Podcast Host, June Grasso | Bloomberg Law Podcast

    In this week's Bloomberg Law Podcast, BSKB’s Leonard Svensson is featured discussing how “Impossible Foods is testing a tastes-like-meat patent in court.”

  • January 5, 2022

    Patent applications: Kite raises the game

    by Hailey Bureau and Olayinka Oladele | Patent applications: Kite raises the game

    Hailey Bureau, Ph.D. (Associate) and Olayinka Oladele (Law Clerk from Texas Southern University's Thurgood Marshall School of Law) recently co-authored and article for WIPR regarding the Federal Circuit's recent "added complexities to the drafting of patent applications for antibody inventions" as a result of the cases Amgen v Sanofi (2021) and Juno Therapeutics v Kite Pharma (2021).

  • September 30, 2021

    Eugene Perez weighs in on the “Restoring America Invents Act”

    by Eileen McDermott | IPWatchdog

    Eugene Perez weighs in on the “Restoring America Invents Act”, proposed by Senators Leahy (D-VT) and Cornyn (R-TX), in an article from IPWatchdog, Inc

  • September 27, 2021

    Q&A with David Bilodeau and Brad Fritz: Rain Computing v. Samsung

    by David Bilodeau, Brad Fritz, and Tom Phillips | WIPR Patents Live

    WIPR Patents Live hosted BSKB Attorneys David Bilodeau (Partner) and Brad Fritz (Associate) in a Q&A with Tom Phillips regarding Rain Computing v. Samsung.

  • September 16, 2021

    MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act"

    by Eileen McDermott | IPWatchdog

    MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act" during the bill's 10 year anniversary in an article from IPWatchdog, Inc.

  • July 7, 2021

    When the Inventor is Artificial

    by MaryAnne Armstrong, Ph. D. | LSIPR

    MaryAnne Armstrong discusses whether the same tests for non-obviousness of biotech patents will be applied to pharma inventions developed using AI.

  • June 22, 2021

    Industry Reacts to the Supreme Court’s Arthrex Ruling: Chaos Averted – or Just Delayed?

    by | IPWatchdog

    Partner, Eugene T. Perez was recently quoted in an article by IPWatchdog regarding this week's U.S. Supreme Court patent decision in United States v. Arthrex, Inc. Et Al.

  • June 17, 2021

    Q&A with MaryAnne Armstrong: The future of AI in the life sciences

    by MaryAnne Armstrong, Ph. D. | LSIPR

    MaryAnne Armstrong, Ph. D., sits down with LSIPR to discuss artificial intelligence's impact on IP industry relating to life sciences and pharmaceuticals.

  • April 16, 2021

    Substitute/Cultivated Meat Technology: A Deep-Dive Patent Landscape Analysis

    by Leonard R. Svensson, Esq. | Birch, Stewart, Kolasch & Birch, LLP

    Substitute/Cultivated Meat Technology: A Deep-Dive Patent Landscape Analysis by Leonard R. Svensson, Esq.

  • March 26, 2021

    Energetics and structure of alanine-rich α-helices via adaptive steered molecular dynamics

    by Co-author Hailey R. Bureau, Ph.D. | Biophysical Journal

  • December 1, 2020

    David A. Bilodeau named to Best Lawyers® list

    by | BSKB News

    Birch, Stewart, Kolasch & Birch, LLP is pleased to announce that David A. Bilodeau has been included in this Edition of The Best Lawyers in America.

  • November 22, 2020

    Printed publications: an evolving doctrine

    by Eugene T. Perez | Printed publications: an evolving doctrine

    While the PTAB’s decision in Hulu provides some guidance for post-grant proceedings, there is still no bright-line rule as to what constitutes a “printed publication”. Eugene Perez of Birch Stewart Kolasch Birch examines current case rulings.

  • November 1, 2020

    BSKB ASSISTS CLIENT IN SUCCESSFUL IPR CHALLENGES TO BIOPHARMACEUTICAL PATENTS FOR TREATING POMPE DISEASE

    by Gerald M. Murphy, Jr. | BSKB News

    BSKB assists client in successful IPR Challenges to Biopharmaceutical Patents for Treating Pompe Disease

  • July 24, 2020

    Washington, D.C. NFL Team Loses Race to the Trademark Office: Does it Matter?

    by Michael. T Smith | IPWatchDog

    In surveys throughout the Washington, D.C. metro area, three possible replacement names have emerged as favorites among the fans: Warriors, Red Wolves, and Redtails. Armed with the knowledge of the name change and the relative popularity of the possible replacement names, two enterprising individuals have applied to obtain a federal trademark registration for the marks WARRIORS, WASHINGTON RED WOLVES, and WASHINGTON REDTAILS, respectively. Neither applicant appears to be connected to the owners of the Washington D.C. professional football team.

  • July 10, 2020

    Could good intentions lead to future danger?

    by MaryAnne Armstrong, Ph.D. | LSIPR

    MaryAnne Armstrong, Ph.D. discusses the potential risks to IP rights with open-access to technology, medicines and devices in the fight against COVID-19 in the latest issue of LSIPR.

Contact Us